Medicare Prescription Drug Price Negotiation Act of 2019

HB 275 Medicare Prescription Drug Price Negotiation Act of 2019

US Congress 116th Congress

Medicare Prescription Drug Price Negotiation Act of 2019
HB-275


About HB-275

Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.

  

Bill Texts

Introduced 01/18/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (38)